Sol-Gel Technologies (SLGL) Return on Capital Employed (QoQ) (2018 - 2026)

Sol-Gel Technologies (SLGL) Return on Capital Employed (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,644.00
Dec 31, 2025 1,495.00
Sep 30, 2025 -2,168.00
Jun 30, 2025 3,336.00
Mar 31, 2025 988.00
Dec 31, 2024 -171.00
Sep 30, 2024 1,529.00
Jun 30, 2024 2,140.00
Mar 31, 2024 -1,417.00
Dec 31, 2023 -5.00
Sep 30, 2023 -522.00
Jun 30, 2023 -1,527.00
Mar 31, 2023 1,135.00
Dec 31, 2022 -4,062.00
Sep 30, 2022 -825.00
Jun 30, 2022 -864.00
Mar 31, 2022 -573.00
Dec 31, 2021 3,866.00
Sep 30, 2021 2,420.00
Jun 30, 2021 -2.00